"We Are Headed in the Right Direction, and the Improvements in Our Key Financial Figures Compared to the Previous Year Are Really Encouraging," Chief Financial Officer Maike Schuh Said in a Statement. Aug 1 (Reuters) - German Chemicals Group Evonik Industries Evkn.de on Thursday Said It Expected Its Core Profit for the Third Quarter to Be "on Par" With That of the Second Quarter.
8月1日(路透社)-德國化學品集團贏創工業 Evkn.de 週四，該公司表示預計其第三季度的核心利潤將與第二季度“大致相同”。
The Speciality Chemicals Maker Said Its Second-Quarter Adjusted Earnings Before Interest, Tax, Depreciation and Amortisation (Ebitda) Was 578 Million Euros ($626 Million), in Line With the Preliminary Figure Published in July.
這家專業化學制造商表示，其第二季度調整後的息稅前利潤、折舊與攤銷(EBITDA)爲57800萬歐元(62600萬美元)，與7月初公佈的 初步數據吻合。 贏創工業確認其年度業績預期，調整後的EBITDA在19億歐元和22億歐元之間，與上月一致。
Evonik, Whose Chemicals Are Used in Products From Autos and Animal Feed to Pfizer and BioNTech's Covid Vaccine, Confirmed Its Annual Outlook for an Adjusted Ebitda of Between 1.9 Billion and 2.2 Billion Euros, Which It Raised Last Month.
這家化學品製造商的化學品用於從汽車和動物飼料到輝瑞和BioNTech的COVID疫苗等產品中。 募資額 贏創工業補充說，其其他關鍵財務指標的前景也沒有改變。
The Outlook for Its Other Key Financial Figures Also Remains Unchanged, Evonik Added.
“我們正在朝着正確的方向發展，與去年相比，我們關鍵財務指標的改善令人鼓舞，”首席財務官梅克·舒(Maike Schuh)在一份聲明中說。
"We Are Headed in the Right Direction, and the Improvements in Our Key Financial Figures Compared to the Previous Year Are Really Encouraging," Chief Financial Officer Maike Schuh Said in a Statement.
舒補充說:“然而，當前的復甦與2023年的非常薄弱相比，我們距離實現我們的目標還有很長的路要走。”
"However, the Current Recovery Compares to a Very Weak 2023, and We Are Still a Long Way From Reaching Our Goals," Schuh Added.
該公司表示，預計其高分子超吸水樹脂業務將在第三季度完成。
The Company Said It Expected the Sale of Its Superabsorbents Business to Be Completed During the Third Quarter.
出售 其超吸收材料業務的交易將在第三季度完成。
($1 = 0.9232 Euros)
($1 = 0.9232歐元)
(Reporting by Anastasiia Kozlova and Amir Orusov in Gdansk; Editing by Milla Nissi)
(文 By Anastasiia Kozlova and Amir Orusov; 編輯 By Milla Nissi)
